Stenocare AS (OCSE:STENO) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OCSE:STENO Stenocare AS OCSE:STENO
49 GF Score
Price kr0.99
GF Value kr2.31
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Stenocare AS FFO per Share?

FFO per Share only applies to REITs.

OCSE:STENO
49GF Score
Stenocare AS OCSE:STENO
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Stenocare AS (OCSE:STENO) Overvalued in 2026?

Based on GuruFocus' analysis, Stenocare AS stock appears to be undervalued. The current stock price of kr0.99 is trading 57.2% below its estimated GF Value™ of kr2.31. GuruFocus considers Stenocare AS to be Possible Value Trap.

Key valuation signals for OCSE:STENO:

  • FFO per Share:
  • GF Value™: kr2.31 vs. price of kr0.99 (57.2% below fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the OCSE:STENO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stenocare AS Business Description

Other Exchanges S7C:Germany
Address Lejrvej 9, Vaerlose, DNK, 93500
Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway.
49GF Score

Get the complete analysis for OCSE:STENO

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.99
Price
kr2.31
GF Value